Environmental and Metabolic Risk Factors Linked to Gallbladder Dysplasia
Metabolites · 08.05.2024 · 14 (5) · 273
DOI: 10.3390/metabo14050273 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Metabolites, online erschienen am 08.05.2024. Verfasst von Andrei Bojan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Sciences, University of Medicine and Pharmacy Grigore T. Popa, 700115 Iasi, Romania. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Gallbladder disorders encompass a spectrum from congenital anomalies to inflammatory and neoplastic conditions, frequently requiring surgical intervention. Epithelial abnormalities like adenoma and metaplasia have the potential to progress to carcinoma, emphasizing the importance of histopathological assessment for early detection of malignancy. Gallbladder cancer (GBC) may be incidentally discovered during cholecystectomy for presumed benign conditions, underscoring the need for a thorough examination. However, the lack of clarity regarding the molecular mechanisms of GBC has impeded diagnostic and therapeutic advancements. Timely detection is crucial due to GBC’s aggressive nature and poor prognosis. Chronic inflammation plays a central role in carcinogenesis, causing DNA damage and oncogenic alterations due to persistent insults. Inflammatory cytokines and microRNAs are among the various mediators contributing to this process. Gallbladder calcifications, particularly stippled ones, may signal malignancy and warrant preemptive removal. Molecular pathways involving mutations in oncogenes and tumor suppressor genes drive GBC pathogenesis, with proposed sequences such as gallstone-induced inflammation leading to carcinoma formation. Understanding these mechanisms, alongside evaluating mucin characteristics and gene mutations, can deepen comprehension of GBC’s pathophysiology. This, in turn, facilitates the identification of high-risk individuals and the development of improved treatment strategies, ultimately enhancing patient outcomes. Thus, in this review, our aim has been to underscore the primary mechanisms underlying the development of gallbladder dysplasia and neoplasia.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgical Sciences, University of Medicine and Pharmacy Grigore T. Popa, 700115 Iasi, Romania.
- Department of Pathophysiology, University of Medicine and Pharmacy Grigore T. Popa, 700115 Iasi, Romania.
- Department of Internal Medicine, University of Medicine and Pharmacy Grigore T. Popa, 700115 Iasi, Romania.
- Department of Biochemistry, University of Medicine and Pharmacy Grigore T. Popa, 700115 Iasi, Romania.
ORCID-Profile: Manuela Ciocoiu, Oana Viola Badulescu, Minerva Codruta Badescu, Liliana Georgeta Foia
Zitieren
APA
Bojan, A., Pricop, C., Ciocoiu, M., Vladeanu, M. C., Bararu Bojan, I., Badulescu, O. V., Badescu, M. C., Plesoianu, C. E., Halitchi, D. I., & Foia, L. G. (2024). Environmental and Metabolic Risk Factors Linked to Gallbladder Dysplasia. Metabolites, 14(5), 273. https://doi.org/10.3390/metabo14050273
Vancouver
Bojan A, Pricop C, Ciocoiu M, Vladeanu MC, Bararu Bojan I, Badulescu OV, et al. Environmental and Metabolic Risk Factors Linked to Gallbladder Dysplasia. Metabolites. 2024;14(5):273. doi:10.3390/metabo14050273
BibTeX
@article{Bojan2024,
author = {Bojan, Andrei and Pricop, Catalin and Ciocoiu, Manuela and Vladeanu, Maria Cristina and Bararu Bojan, Iris and Badulescu, Oana Viola and Badescu, Minerva Codruta and Plesoianu, Carmen Elena and Halitchi, Dan Iliescu and Foia, Liliana Georgeta},
title = {Environmental and Metabolic Risk Factors Linked to Gallbladder Dysplasia},
journal = {Metabolites},
year = {2024},
volume = {14},
number = {5},
pages = {273},
doi = {10.3390/metabo14050273}
}
EUVIMED